Company / Shareholders' Equity
Natera, Inc. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$1.7B
FY2025
5-year range
$486.2M / $1.7B
FY2021-FY2025
Trend
+43.2%
vs FY2024
Sector context
#60 of 161
Health Care
What the data says
At $1.7B, Natera, Inc.'s shareholders' equity ranks #60 of 161 in the Health Care sector. Shareholders' Equity has increased for 3 consecutive years, from $486M in FY2022 to $1.7B in FY2025.
Based on SEC 10-K filings.
$1.7B in FY2025 with a 5-year CAGR of +121.4%.
Improved from $765M to $1.7B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +52.1%
- 5-Year CAGR
- +121.4%
- 10-Year CAGR
- -
Sector benchmark
#60 of 161 in Health CareTop 37% of 161This company $1.7B Sector average $5.1B
▼
-66.2% below sector average
Key checks
Key Insights
- Natera, Inc.'s shareholders' equity has grown for 3 consecutive years.
- 5-year CAGR of +121.4%, indicating consistent growth.
- In FY2025, shareholders' equity increased 43.2% year-over-year.
- Ranks #60 out of 161 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.7B | +43.2% |
| FY2024 | $1.2B | +56.2% |
| FY2023 | $765.3M | +57.4% |
| FY2022 | $486.2M | -25.6% |
| FY2021 | $653.3M | +1931.3% |
| FY2020 | $32.2M | +26.5% |
| FY2019 | $25.4M | -21.0% |
| FY2018 | $32.2M | +26.5% |
| FY2017 | $25.4M | -82.3% |
| FY2016 | $143.6M | -36.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026